THE DUO™ SYSTEM

A whole new kind of accessibility.

DUO™ is designed to improve quality of life while expanding the treatable patient population and enabling more physicians to treat patients.

System Overview

CroíValve has developed a novel, minimally invasive solution for severe+ Tricuspid Regurgitation (TR). TR is a highly prevalent disease in people over 65 years of age with limited treatment options today. The DUO™ System is designed to expand these treatment options.

Treat more patients. Enable more physicians.

The DUO™ System preserves the native anatomy with its novel design.

Coaptation Valve

The coaptation valve fills the leak and actively adapts to varying anatomy and leaks. DUO™ works in big hearts and small hearts, independent of coaptation gap and annulus size—working in tandem with the native leaflets—allowing it to treat a broad patient base, and support positive right heart remodeling.

Anchor System

To preserve the right heart, we created an anchor system that is adaptable and supportive of right heart remodeling. It’s anchored within the SVC with a stent, allowing the right heart to function without device interaction.

A bold new way to treat a broad patient population.

Large Annulus Sizes

DUO is independent of the annulus size.

CEID Leads

Compatible with pre-existing CEID leads, DUO™ adapts to the leak profile.

Large Coaptation Gaps

DUO is independent of the coaptation gap size.

Advanced Disease

DUO is designed to treat patients with advanced disease.

New. Adaptable. Scalable.

With a short learning curve to enable treatment of a broad population of patients, the DUO™ System can be deployed with ease while employing self centering technology for optimized positioning. The best aspect? Less reliance on expert imaging and the ability to treat complex anatomies and advanced-stage disease.

The clinical evidence is expanding.

The DUO System is currently under clinical investigation.